SPDR S&P Pharmaceuticals is an open-end investment management company. The Fund seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. As of June 30 2015, the Fund's total assets and investment portfolio totaled $1,324,794,738 and $1,323,892,831, respectively. We show 105 historical shares outstanding datapoints in our coverage of XPH's shares outstanding history.
Understanding the changing numbers of XPH shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like XPH versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching XPH by allowing them to research XPH shares outstanding history
as well as any other stock in our coverage universe. |
Free XPH Email Alerts:
Video: Shares Outstanding Importance
